Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David Moreno-Pérez is active.

Publication


Featured researches published by David Moreno-Pérez.


Enfermedades Infecciosas Y Microbiologia Clinica | 2013

Tos ferina en España. Situación epidemiológica y estrategias de prevención y control. Recomendaciones del Grupo de Trabajo de Tos ferina

Magda Campins; David Moreno-Pérez; Angel Gil-de Miguel; Fernando González-Romo; Fernando A. Moraga-Llop; Javier Arístegui-Fernández; Anna Goncé-Mellgren; José M. Bayas; Lluís Salleras-Sanmartí

A large increase of pertussis incidence has been observed in recent years in countries with high vaccination coverage. Outbreaks of pertussis are increasingly being reported. The age presentation has a bipolar distribution: infants younger 6months that have not initiated or completed a vaccination schedule, and adolescents and adults, due to the lost of natural or vaccine immunity over time. These epidemiological changes justify the need to adopt new vaccination strategies in order to protect young infants and to reduce pertussis incidence in all age groups. Adolescents and adults immunization must be a priority. In the first group, strategy is easy to implement, and with a very low additional cost (to replace dT vaccine by dTap one). Adult vaccination may be more difficult to implement; dT vaccine decennial booster should be replaced by dTap. The immunization of household contacts of newborn infants (cocooning) is the strategy that has a most important impact on infant pertussis. Recently, pregnant women vaccination (after 20weeks of gestation) has been recommended in some countries as the most effective way to protect the newborn.


Journal of Clinical Virology | 2012

Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period

Teresa del Rosal; Fernando Baquero-Artigao; Daniel Blázquez; Antoni Noguera-Julian; David Moreno-Pérez; Alejandro Reyes; Javier Vilas

BACKGROUND Congenital cytomegalovirus (CMV) is an important cause of sensorineural hearing loss. Ganciclovir treatment in the neonatal period may prevent hearing deterioration in infants with central nervous system (CNS) involvement. However, there are hardly any data regarding antiviral treatment begun beyond the neonatal period. OBJECTIVES To describe the hearing outcome of infants with congenital CMV infection and CNS involvement treated beyond the neonatal period. To assess the tolerability and toxicity of prolonged valganciclovir treatment in these patients. STUDY DESIGN Retrospective case series of infants with congenital CMV infection and CNS involvement who started antiviral treatment beyond the neonatal period in Spain between 2008 and 2010. Hearing was tested by brainstem-evoked response at the time of diagnosis, 6 and 12 months after the beginning of treatment. RESULTS Thirteen cases were included. All received oral valganciclovir, and 4 also intravenous ganciclovir. Median valganciclovir treatment duration was 6 months and it was well tolerated. Six patients developed neutropenia, none requiring granulocyte colony-stimulating factor. Eleven children (85%) had hearing defects at baseline, compared to 50% at 12 months. By ears, 18 ears showed hearing loss at baseline (7 mild, 3 moderate, 8 severe). At 12 months, 9 remained stable, 7 had improved and none had worsened. In 8 normal ears at baseline, no deterioration was found at 12 months. CONCLUSIONS Valganciclovir treatment is well tolerated. It may improve or preserve the auditory function of congenitally cytomegalovirus-infected patients treated beyond the neonatal period for at least one year after the beginning of antiviral treatment.


Anales De Pediatria | 2010

Diagnostico de la tuberculosis en la edad pediatrica

David Moreno-Pérez; A. Andrés Martín; N. Altet Gómez; F. Baquero-Artigao; A. Escribano Montaner; D. Gómez-Pastrana Durán; R. González Montero; M.J. Mellado Peña; C. Rodrigo-Gonzalo-de-Liria; M.J. Ruiz Serrano

Tuberculosis is one of the most important health problems worldwide. There are an increasing number of cases, including children, due to different reasons in developed countries. The most likely determining cause is immigration from highly endemic areas. Measures to optimise early and appropriate diagnosis of the different forms of tuberculosis in children are a real priority. Two Societies of the Spanish Paediatric Association (Spanish Society of Paediatric Infectology and Spanish Society of Paediatric Pneumology) have agreed this Consensus Document in order to homogenise diagnostic criteria in paediatric patients.


Anales De Pediatria | 2014

El calendario de vacunación común de mínimos para España: posicionamiento del CAV-AEP

J. Arístegui Fernández; David Moreno-Pérez

E d e e c a C p d La extravagante situación de España, con 19 calendarios con diferencias en contenidos y cronologías1, no argumentadas desde el punto de vista sanitario ni social, es única en el mundo. En algunos países, pero escasos, existen algunos calendarios oficiales diferentes, pero no en la cuantía y disparidad existente en España, lo que conduce a una penosa fotografía de la sanidad española, tanto en nuestra sociedad como a nivel internacional.


Anales De Pediatria | 2012

Etiología y diagnóstico de la neumonía adquirida en la comunidad y sus formas complicadas

A. Andrés Martín; David Moreno-Pérez; S. Alfayate Miguélez; J.A. Couceiro Gianzo; M.L. García García; J. Korta Murua; M.I. Martínez León; C. Muñoz Almagro; I. Obando Santaella; G. Pérez Pérez

Community Acquired Pneumonia (CAP) is a common childhood disease, involving several paediatric subspecialties in its diagnosis and treatment. This has prompted the Spanish Society of Paediatric Pulmonology (SENP) and the Spanish Society of Paediatric Infectious Diseases (SEIP) to prepare a consensus document on the diagnosis of CAP, assessing the practical aspects by means of evidence-based medicine. It discusses the aetiology and epidemiology, with the current changes and the validity of certain laboratory tests, such as acute phase reactants, microbiological and imaging techniques, guiding the paediatricians in the real value of these tests.


Enfermedades Infecciosas Y Microbiologia Clinica | 2007

El virus de la gripe en pediatría. Un motivo de hospitalización

Marta Cruz-Cañete; David Moreno-Pérez; Antonio Jurado-Ortiz; Francisco Jesus Garcia-Martin; López-Siles J; Olalla-Martín L

INTRODUCTION: Influenza infection in infants and children has been classically underestimated due to its non-specific symptoms, which sometimes overlap those of other respiratory viruses. Infants under 24 months are a risk group and school-aged children are a major source of influenza infection. The aim of this study was to describe the clinical and epidemiological characteristics of children hospitalized for flu, including co-infections and the differences as compared to other respiratory viruses. The effectiveness of a test for rapid diagnosis of this condition was assessed. MATERIAL AND METHODS: Prospective, descriptive study in children < 5 years of age hospitalized from 1 December 2003 to 28 February 2004 with respiratory processes or fever of unknown origin. Polymerase chain reaction (PCR) testing for influenza A (IA) and B, respiratory syncytial virus A (RSV-A) and B, and parainfluenza 1, 2 and 3 was performed in nasopharyngeal aspirate, as well as a test for rapid diagnosis of influenza. RESULTS: A total of 203 samples were included. PCR was positive for influenza in 11.3% (23/203); IA in 21 cases (20 H3N2, 1 H1N1). Co-infections were frequent (10/23), mainly IA with RSV-A. The rapid diagnostic test had a sensitivity of 45.5%. Median age of patients with flu was 4.87 months (5 days-3.5 years); 69.5% were < 24 months. Gastrointestinal symptoms were associated with fever and respiratory symptoms more often than in other viral infections (P < 0.05). Only 2.9% of patients with a recommendation for flu vaccination had received the vaccination. CONCLUSIONS: Flu is a major cause of hospitalization in infants and children, particularly those aged < 24 months. Early diagnosis of this condition may avoid unnecessary use of additional tests and antibiotics. Vaccination coverage is low; vaccination between 6 and 24 months seems advisable.


Anales De Pediatria | 2015

Neumonía adquirida en la comunidad: tratamiento de los casos complicados y en situaciones especiales. Documento de consenso de la Sociedad Española de Infectología Pediátrica (SEIP) y Sociedad Española de Neumología Pediátrica (SENP) ◊

David Moreno-Pérez; A. Andrés Martín; A. Tagarro García; A. Escribano Montaner; J. Figuerola Mulet; J.J. García García; Antonio Moreno-Galdó; C. Rodrigo Gonzalo de Lliria; J. Saavedra Lozano

The incidence of community-acquired pneumonia complications has increased during the last decade. According to the records from several countries, empyema and necrotizing pneumonia became more frequent during the last few years. The optimal therapeutic approach for such conditions is still controversial. Both pharmacological management (antimicrobials and fibrinolysis), and surgical management (pleural drainage and video-assisted thoracoscopic surgery), are the subject of continuous assessment. In this paper, the Spanish Society of Paediatric Infectious Diseases and the Spanish Society of Paediatric Chest Diseases have reviewed the available evidence. Consensus treatment guidelines are proposed for complications of community-acquired pneumonia in children, focusing on parapneumonic pleural effusion. Recommendations are also provided for the increasing population of patients with underlying diseases and immunosuppression.


International Journal of Infectious Diseases | 2016

Paradoxical reaction in immunocompetent children with tuberculosis.

Begoña Carazo Gallego; David Moreno-Pérez; Esmeralda Núñez Cuadros; Alba Mesa Fernandez; María Martin Cantero; Pablo Obando Pacheco; Antonio Urda Cardona

BACKGROUND A paradoxical reaction (PR) during anti-tuberculosis treatment is a phenomenon that is poorly studied in immunocompetent children. It is defined as a clinical or radiological worsening of pre-existing tuberculosis (TB) disease. METHODS A retrospective descriptive study of children younger than 14 years of age was performed; these children developed PR during the years 2009 to 2014, following a diagnosis of TB. Demographic characteristics, microbiological results, treatment and outcome data were collected. RESULTS Of 51 children diagnosed with TB, five (9.8%) developed a PR; four of these children had pulmonary TB and the remaining patient had miliary TB with central nervous system involvement. The PR occurred at a median of 42 days (range 23-53 days) after initiating therapy. Corticosteroids were started when PR was suspected, at a median dose of 1mg/kg/day. Clinical and radiological improvement was noted in all cases, with a median clinical regression time of 10.5 days (range 3-15 days) and a median radiological regression time of 45 days (range 26-105 days). No sequelae were described in any patient. CONCLUSIONS PR in immunocompetent children during anti-tuberculosis treatment is not such an unusual reaction. Treatment with corticosteroids may be useful for the resolution of PR.


Anales De Pediatria | 2017

Epidemiología de los ingresos por bronquiolitis en el sur de Europa: análisis de las epidemias 2010-2015

José Miguel Ramos-Fernández; Eva Pedrero-Segura; Mario Gutiérrez-Bedmar; Beatriz Delgado-Martín; Ana María Cordón-Martínez; David Moreno-Pérez; Antonio Urda-Cardona

espanolIntroduccion La renovacion de las guias de practica clinica sobre la bronquiolitis aguda (BA) obliga a reevaluar las consecuencias de su implantacion. Pretendemos actualizar las principales variables clinico-epidemiologicas en pacientes ingresados por BA en el sur de Europa y analizar las causas de la estancia prolongada. Pacientes y metodo Estudio retrospectivo de ingresos por BA durante 5 epidemias (2010-2015), con descripcion de las principales variables clinico-epidemiologicas y analisis por regresion logistica de los factores asociados a mayor estancia. Resultados El inicio de la epidemia ocurrio entre las semanas cuarta de septiembre y tercera de octubre. De los menores de 2 anos (42.530 ninos), el 15,21% (6.468 pacientes) acudieron a urgencias por BA y el 2,36% ingresaron (1.006 pacientes), con un 18,5% de prematuros. El 12,2% tenian peso al nacimiento inferior a 2.300g. El 21,1% eran menores de un mes, consultaron por apnea asociada el 10,8%, ingesta inferior al 50% en el 31,1% y presentaban sobreinfeccion bacteriana el 13,1%. Estos factores se asociaron de forma independiente a la estancia prolongada. La mediana de estancia fue de 5 dias y la proporcion de ingresos en la unidad de cuidados intensivos pediatricos (UCIP) del 8,5% de los casos. Conclusiones El inicio de la epidemia de la bronquiolitis mostro una variabilidad de hasta 4 semanas en nuestro medio. Tras 5 anos de la implantacion de la guia de practica clinica, la incidencia de ingresos esta en torno al 2,3% y parece estable respecto a estudios previos. La edad media de los pacientes desciende a 2,4 meses, aunque con una proporcion similar de ingresos en la UCIP de un 8,5%. Los factores de riesgo independiente asociados a una estancia hospitalaria mas prolongada fueron: bajo peso al nacimiento, edad menor de un mes, apneas previas al ingreso, ingesta inferior al 50% y la sobreinfeccion bacteriana grave, donde la infeccion respiratoria supero la prevalencia de infeccion del tracto urinario grave. EnglishIntroduction The renewal of clinical practice guidelines on acute bronchiolitis (AB) requires the re-assessment of the consequences of their implementation. An update is presented on the main clinical and epidemiological variables in patients hospitalised due to AB in Southern Europe and an analysis made of the causes associated with longer hospital stay. Patients and method A retrospective study was conducted on patients admitted to hospital due to AB during 5 epidemics (2010-2015), with an analysis of the major clinical and epidemiological variables. A logistic regression analysis was performed on the factors associated with a longer hospital stay. Results The beginning of the epidemic occurred between the 4th week of September and the 3rd week of October. Of those children under 2 years (42,530), 15.21% (6,468 patients) attended paediatric emergency department due to having AB, and 2.36% (1,006 patients) were admitted. Of these, 18.5% of were premature, 12.2% had a birth weight Conclusions The beginning of the bronchiolitis epidemic showed a variability of up to 4 weeks in this region. Five years after implementing the new guidelines, the incidence of admissions was approximately 2.3%, and appeared stable compared to previous studies. The mean age of the patients decreased to 2.4 months, although with a similar proportion of PICU admissions of 8.5%. Independent factors associated with prolonged stay were: low birth weight, age less than one month, apnoea prior-to-admission, intake of less than 50%, and severe bacterial superinfection. Respiratory bacterial infection exceeded the prevalence of urinary tract infection.INTRODUCTION The renewal of clinical practice guidelines on acute bronchiolitis (AB) requires the re-assessment of the consequences of their implementation. An update is presented on the main clinical and epidemiological variables in patients hospitalised due to AB in Southern Europe and an analysis made of the causes associated with longer hospital stay. PATIENTS AND METHOD A retrospective study was conducted on patients admitted to hospital due to AB during 5 epidemics (2010-2015), with an analysis of the major clinical and epidemiological variables. A logistic regression analysis was performed on the factors associated with a longer hospital stay. RESULTS The beginning of the epidemic occurred between the 4th week of September and the 3rd week of October. Of those children under 2 years (42,530), 15.21% (6,468 patients) attended paediatric emergency department due to having AB, and 2.36% (1,006 patients) were admitted. Of these, 18.5% of were premature, 12.2% had a birth weight <2,300g, 21.1% were younger than 1 month, 10.8% consulted for associated apnoea, 31.1% had an intake <50%, and 13.1% had bacterial superinfection. These factors were independently associated with prolonged stay. The median length of stay was 5 days, and 8.5% of cases were admitted to a paediatric intensive care unit (PICU). CONCLUSIONS The beginning of the bronchiolitis epidemic showed a variability of up to 4 weeks in this region. Five years after implementing the new guidelines, the incidence of admissions was approximately 2.3%, and appeared stable compared to previous studies. The mean age of the patients decreased to 2.4 months, although with a similar proportion of PICU admissions of 8.5%. Independent factors associated with prolonged stay were: low birth weight, age less than one month, apnoea prior-to-admission, intake of less than 50%, and severe bacterial superinfection. Respiratory bacterial infection exceeded the prevalence of urinary tract infection.


Anales De Pediatria | 2015

Neumonía adquirida en la comunidad: tratamiento ambulatorio y prevención

David Moreno-Pérez; A. Andrés Martín; A. Tagarro García; A. Escribano Montaner; J. Figuerola Mulet; J.J. García García; Antonio Moreno-Galdó; C. Rodrigo Gonzalo de Lliria; J. Ruiz Contreras; J. Saavedra Lozano

There have been significant changes in community acquired pneumonia (CAP) in children in the last decade. These changes relate to epidemiology and clinical presentation. Resistance to antibiotics is also a changing issue. These all have to be considered when treating CAP. In this document, two of the main Spanish pediatric societies involved in the treatment of CAP in children, propose a consensus concerning therapeutic approach. These societies are the Spanish Society of Paediatric Infectious Diseases and the Spanish Society of Paediatric Chest Diseases. The Advisory Committee on Vaccines of the Spanish Association of Paediatrics (CAV-AEP) has also been involved in the prevention of CAP. An attempt is made to provide up-to-date guidelines to all paediatricians. The first part of the statement presents the approach to ambulatory, previously healthy children. We also review the prevention with currently available vaccines. In a next second part, special situations and complicated forms will be addressed.

Collaboration


Dive into the David Moreno-Pérez's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Antonio Moreno-Galdó

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge